Medacist for Risk & Compliance
Your Ally in Informed Decision-Making
Medacist helps you manage your complex, multi-department network of risks big and small. Let us help lighten the load of identifying and analyzing drug diversion issues.
Keep Your Organization Out of Harm’s Way
Medacist provides people-powered support and cutting-edge solutions to help you optimize risk management with confidence and control.
Get a Head Start on Drug Diversion Prevention
The most effective way to combat drug diversion is prevent it from occurring in the first place. Our platform helps you proactively identify and analyze any drug diversion risk, taking much of the strain off your shoulders so you can focus on delivering the best patient care possible.
Be in The Know on All Things Drug Diversion
Through our suite of diversion analytics tools, you get all the details of a drug diversion at the moment of identification. This makes iit that much easier to come up with a plan of resolution with all relevant stakeholders.
A Helping Hand Can Make All The Difference
Managing your risk and compliance ecosystem can often feel like an uphill battle. With over 24 years of industry experience, Medacist is well-equipped to provide individualized risk management support as needed.
Work Closely & Confidently with Stakeholders
Through the Medacist platform, easily collaborate with other stakeholders who need to be involved in risk and compliance issues. Ensure nursing, pharmacy, and billing leadership are all on the same page when it comes to the best path forward.
Had we had RxAuditor Investigate up sooner, we would have easily detected this individual at the onset.”
RxAuditor Investigate does a fantastic job of taking the top high-risk users of controlled substances in our facility and displays them in an easy to view diversion risk dashboard. To research diversion is a needle in a haystack, but with RxAuditor Investigate it brings that haystack down to a more manageable size.”
I would like to give RxAuditor Investigate credit for the “aha moment”. Our diversion team (which is multidisciplinary) was very impressed that the two most recent people we had been investigating for possible diversion were confirmed by RxAuditor Investigate. Well done!”